Remove topic pharma
article thumbnail

PwC’s Pharma & Life Sciences Hot Topics 2020

Pharma Business Blog

Find out more about each of PwC’s Pharma & Life Sciences Hot Topics 2020 in the attached PDF below. Happy to discuss to the topics and their impact on your business with you personally. Maire Walsh, Partner Leader Pharma & Life Science Tax, PwC Switzerland Tel.: +41

article thumbnail

Leo Pharma's topical JAK drug posts phase 3 win in chronic hand eczema

Fierce Pharma

Leo Pharma's topical JAK drug posts phase 3 win in chronic hand eczema zbecker Mon, 02/13/2023 - 12:26

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Executive Interviews at Digital Pharma East 2023

Fierce Pharma

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

article thumbnail

Online HPAPI Summit takes on key pharma ingredients topics

Outsourcing Pharma

The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.

59
article thumbnail

Chiesi’s $1.25B Amryt Buy Pays Off with FDA Approval of Filsuvez

BioSpace

Chiesi Global Rare Diseases gained access to the Filsuvez topical gel in January 2023, when it bought Amryt Pharma. Tuesday’s approval comes nearly two years after an initial rejection by the regulator.

article thumbnail

(“OKYO” or the “Company”) – OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain

BioTech 365

(“OKYO” or the “Company”) – OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain (“OKYO” or the “Company”) – OKYO Pharma Announces Positive Data and Results in an Animal Model using … Continue reading (..)

40
article thumbnail

Leo scores again in hand eczema with its JAK inhibitor cream

Fierce Pharma

It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgoci | It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgocitinib to treat atopic dermatitis.

Trials 98